4//SEC Filing
BONDURANT STUART 4
Accession 0001181431-11-052785
CIK 0001484478other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 5:04 PM ET
Size
9.0 KB
Accession
0001181431-11-052785
Insider Transaction Report
Form 4
BONDURANT STUART
Director
Transactions
- Award
Stock Options (to buy)
2011-10-12+8,825→ 8,825 totalExercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying)
Holdings
- 3,896
Common Stock
- 8,675
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (8,675 underlying) - 17,570
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (17,570 underlying)
Footnotes (3)
- [F1]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F2]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F3]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeother
Related Parties
1- filerCIK 0001181152
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 5:04 PM ET
- Size
- 9.0 KB